|
Solvent |
mg/mL |
mM |
| Solubility |
| Soluble in DMSO |
0.0 |
100.00 |
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.
Preparing Stock Solutions
The following data is based on the
product
molecular weight
241.29
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Feng Z, Chen G, Zhang J, Zhu H, Yu X, Yin Y, Zhang X. Characterization and Complete Genome Analysis of the Carbazomycin B-Producing Strain Streptomyces luteoverticillatus SZJ61. Curr Microbiol. 2019 Sep;76(9):982-987. doi: 10.1007/s00284-019-01711-x. Epub 2019 Jun 5. PMID: 31168648.
2: Wu S, Harada S, Morikawa T, Nishida A. Total Synthesis of Carbazomycins A and B. Chem Pharm Bull (Tokyo). 2018;66(2):178-183. doi: 10.1248/cpb.c17-00851. PMID: 29386469.
3: Sako M, Ichinose K, Takizawa S, Sasai H. Short Syntheses of 4-Deoxycarbazomycin B, Sorazolon E, and (+)-Sorazolon E2. Chem Asian J. 2017 Jun 19;12(12):1305-1308. doi: 10.1002/asia.201700471. Epub 2017 May 16. PMID: 28418587.
4: Markad SB, Argade NP. Diversity oriented convergent access for collective total synthesis of bioactive multifunctional carbazole alkaloids: synthesis of carbazomycin A, carbazomycin B, hyellazole, chlorohyellazole, and clausenaline D. Org Lett. 2014 Oct 17;16(20):5470-3. doi: 10.1021/ol502721r. Epub 2014 Oct 9. PMID: 25296703.
5: Kato S, Kawasaki T, Urata T, Mochizuki J. In vitro and ex vivo free radical scavenging activities of carazostatin, carbazomycin B and their derivatives. J Antibiot (Tokyo). 1993 Dec;46(12):1859-65. doi: 10.7164/antibiotics.46.1859. PMID: 8294245.
6: Iwatsuki M, Niki E, Kato S. Antioxidant activities of natural and synthetic carbazoles. Biofactors. 1993 May;4(2):123-8. PMID: 8394091.
7: Kaneda M, Kitahara T, Yamasaki K, Nakamura S. Biosynthesis of carbazomycin B. II. Origin of the whole carbon skeleton. J Antibiot (Tokyo). 1990 Dec;43(12):1623-6. doi: 10.7164/antibiotics.43.1623. PMID: 2276984.
8: Hook DJ, Yacobucci JJ, O'Connor S, Lee M, Kerns E, Krishnan B, Matson J, Hesler G. Identification of the inhibitory activity of carbazomycins B and C against 5-lipoxygenase, a new activity for these compounds. J Antibiot (Tokyo). 1990 Oct;43(10):1347-8. doi: 10.7164/antibiotics.43.1347. PMID: 2258335.
9: Yamasaki K, Kaneda M, Watanabe K, Ueki Y, Ishimaru K, Nakamura S, Nomi R, Yoshida N, Nakajima T. New antibiotics, carbazomycins A and B. III. Taxonomy and biosynthesis. J Antibiot (Tokyo). 1983 May;36(5):552-8. doi: 10.7164/antibiotics.36.552. PMID: 6874571.
10: Sakano K, Nakamura S. New antibiotics, carbazomycins A and B. II. Structural elucidation. J Antibiot (Tokyo). 1980 Sep;33(9):961-6. doi: 10.7164/antibiotics.33.961. PMID: 7440417.
11: Sakano K, Ishimaru K, Nakamura S. New antibiotics, carbazomycins A and B. I. Fermentation, extraction, purification and physico-chemical and biological properties. J Antibiot (Tokyo). 1980 Jul;33(7):683-9. doi: 10.7164/antibiotics.33.683. PMID: 7410212.
